Evidence map›Paper›PMID 39263839›Full record

ArticleAdvanced healthcare materials2025

Dye-Based Fluorescent Organic Nanoparticles, New Promising Tools for Optogenetics.

Jérémy Lesas, Thomas C M Bienvenu, Eleonore Kurek, Jean-Baptiste Verlhac, Zoé Grivet, Maude Têtu, Delphine Girard, Frédéric Lanore, Mireille Blanchard-Desce, Cyril Herry and 2 more

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jérémy LesasNeurocentre Magendie, INSERM U1215, Université de Bordeaux, Bordeaux, 33000, France.ORCID 0009-0004-9380-053X
Thomas C M BienvenuCentre Hospitalier Charles Perrens, Pôle de Psychiatrie Générale et Universitaire, 121 rue de la Béchade, Bordeaux, 33076, France.ORCID 0000-0002-7416-0504
Eleonore KurekInstitut des Sciences Moléculaires, UMR CNRS 5255, Université de Bordeaux, Talence, 33400, France.ORCID 0009-0002-7293-5334
Jean-Baptiste VerlhacInstitut des Sciences Moléculaires, UMR CNRS 5255, Université de Bordeaux, Talence, 33400, France.ORCID 0000-0001-7351-7762
Zoé GrivetNeurocentre Magendie, INSERM U1215, Université de Bordeaux, Bordeaux, 33000, France.ORCID 0000-0001-9101-1212
Maude TêtuNeurocentre Magendie, INSERM U1215, Université de Bordeaux, Bordeaux, 33000, France.ORCID 0000-0002-5185-962X
Delphine GirardNeurocentre Magendie, INSERM U1215, Université de Bordeaux, Bordeaux, 33000, France.ORCID 0000-0002-4466-6926
Frédéric LanoreInstitut Interdisciplinaire de NeuroSciences, UMR CNRS 5297, Université de Bordeaux, Bordeaux, 33000, France.ORCID 0000-0003-4316-6855
Mireille Blanchard-DesceInstitut des Sciences Moléculaires, UMR CNRS 5255, Université de Bordeaux, Talence, 33400, France.ORCID 0000-0002-1572-9545
Cyril HerryNeurocentre Magendie, INSERM U1215, Université de Bordeaux, Bordeaux, 33000, France.ORCID 0000-0003-2973-0843
Jonathan DanielInstitut des Sciences Moléculaires, UMR CNRS 5255, Université de Bordeaux, Talence, 33400, France.ORCID 0000-0003-1317-3165
Cyril DejeanNeurocentre Magendie, INSERM U1215, Université de Bordeaux, Bordeaux, 33000, France.ORCID 0000-0002-2592-7502

Funding

Agence Nationale de la Recherche ANR-22-CE18-0035-02Université de Bordeaux
6 · The paper itself

Abstract

Dye-based fluorescent organic nanoparticles are a specific class of nanoparticles obtained by nanoprecipitation in water of pure dyes only. While the photophysical and colloidal properties of the nanoparticles strongly depend on the nature of the aggregated dyes, their excellent brightness in the visible and in the near infrared make these nanoparticles a unique and versatile platform for in vivo application. This article examines the promising utilization of these nanoparticles for in vivo optogenetics applications. Their photophysical properties as well as their biocompatibility and their capacity to activate Chrimson opsin in vivo through the fluorescence reabsorption process are demonstrated. Additionally, an illustrative example of employing these nanoparticles in fear reduction in mice through closed-loop stimulation is presented. Through an optogenetic methodology, the nanoparticles demonstrate an ability to selectively manipulate neurons implicated in the fear response and diminish the latter. Dye-based fluorescent organic nanoparticles represent a promising and innovative strategy for optogenetic applications, holding substantial potential in the domain of translational neuroscience. This work paves the way for novel therapeutic modalities for neurological and neuropsychiatric disorders.

Indexed as

Fluorescent DyesNanoparticlesOptogeneticsAnimalsHumansMiceFluorescent Dyesclosed‐loopfluorescenceneurostimulationoptogeneticorganic nanoparticlestwo‐photon absorption

Identifiers

PMID39263839
PMCPMC11730699

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.